Correction: Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165339/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.
by: Giaele Moretti, et al.
Published: (2025-01-01) -
Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.
by: Giaele Moretti, et al.
Published: (2023-01-01) -
Maculopathy after long-term use of fondaparinux, a heparin mimetic and heparanase inhibitor
by: Benjamin R. Lin, et al.
Published: (2025-06-01) -
Impact of low-molecular-weight heparins on survival of cancer patients
by: V. V. Ptushkin
Published: (2022-11-01) -
Influence of low molecular weight heparin on cancer patients’ survival
by: V. V. Ptushkin
Published: (2014-07-01)